Meet our panel of medical specialists

Research Review Australia works with over 70 local medical specialists to select and advise on the most important research from around the world. They advise on what really matters, what impact it has on local healthcare and what we need to do in our daily practice to accomodate new skills and knowledge. Select a category below to see more about each of our expert advisors.

Associate Professor Alexander Guminski

Associate Professor Alexander Guminski

Associate Professor Alexander Guminski is a medical oncologist working in head and neck cancer, genito-urinary and non-melanoma skin cancers. He has interests in novel biological agents and immunotherapy for treatment of advanced cancers. Specific interests include treatment sequencing, combinations of immunotherapy with radiotherapy, peptide receptor radionuclide therapy and conventional chemotherapy, and use of targeted agents in selected patients. Clinical appointments are at Royal North Shore Hospital, North Shore Private and Mater Hospitals in Sydney. He is a Clinical Associate Professor in Medicine at the University of Sydney Northern Campus, adjunct research fellow at the Kolling Institute in Sydney and clinical lead for trials in the Northern Sydney Health District... read more »

Associate Professor Craig Gedye

Associate Professor Craig Gedye

I’m a physician/scientist, dual trained as a medical oncologist, clinical trialist and basic science researcher. I work for patients with melanoma, brain, kidney, prostate, testis, and bladder cancer at the Calvary Mater Newcastle, and I'm the Director, HMRI Clinical TrialsI and Clinical Research Director at the NSW Statewide Biobank. I chair the Renal Cancer Subcommittee for ANZUP Cancer Trials Group, and I’m delighted to be the Coordinating Principal Investigator for the KeyPAD and UNISON trials. I undertake translational and basic cancer research at the Hunter Medical Research Institute, University of Newcastle. My research focus is on cancer heterogeneity; why treatments work for some patients but not others. This challenging research spans the translational spectrum from patient experience to basic science... read more »